![]() Well, we could quickly drown in numbers here, so let’s get some out of the way, immediately. Peter Neumann, Joshua Cohen, and Daniel Ollendorf - all of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center. I’m Joe Elia and I’m here with the authors of a book that came out last year titled, “The Right Price: A Value-Based Prescription for Drug Costs.” The authors are Drs. You’re listening to Clinical Conversations from the NEJM Group. Who sets those prices? What is their basis? The US has the highest drug prices around, right? And it threatens household as well as governmental budgets. Listen in and let us know what you think. Our three guests have written a book about the problem, “The Right Price: A value-based prescription for drug costs.” And although they don’t have a definitive answer, they do offer recommendations, interesting observations, and a way forward. Is the problem intractable, or just an exercise in chaos? In a capitalist democracy, many parties - the drug companies, medical associations, consumer groups - get to lobby their points of view. ![]() control prescription drug pricing as they do in the U.K., where per-capita spending is less than half our level?
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |